Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8889583rdf:typepubmed:Citationlld:pubmed
pubmed-article:8889583lifeskim:mentionsumls-concept:C0031485lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0031456lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C1609982lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0243102lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:8889583lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:8889583pubmed:issue3lld:pubmed
pubmed-article:8889583pubmed:dateCreated1997-1-23lld:pubmed
pubmed-article:8889583pubmed:abstractTextWe have used three complementary in vitro systems to express the human phenylalanine hydroxylase (PAH) gene at high levels. Recombinant PAH was expressed in Escherichia coli (as a fusion protein), in human kidney cells and in a cell-free in vitro transcription-translation system. These systems were used to characterize a novel kinetic variant form (D143G) of the enzyme. The recombinant D143G mutant enzyme had the same physicochemical properties as the wild-type PAH and was stable when expressed in eukaryotic cells. Enzyme activity studies of the D143G mutant enzyme, produced in the three expression systems, revealed a kinetic variant form with reduced affinity for L-Phe (about 2.4-fold increase in the S0.5 value) as well as reduced affinity for tetrahydrobiopterin (BH4) (about 2-fold increase in the apparent Km). At standard assay conditions (1 mM L-Phe, t5 microM BH4) the residual activity of the mutant enzyme was high and variable (52%, 33%, and 102%) when analysed in the three different systems. The high residual activities of the mutant enzyme obtained at these conditions were not in agreement with the classical PKU phenotype found in a patient compound heterozygous for the termination mutation G272X and the novel D143G mutation. However, when the D143G mutant enzyme was assayed at lower concentrations of L-Phe (100-300 microM) and BH4 (10 microM) the residual activities were compatible with severely reduced hydroxylation of L-Phe and the classical PKU phenotype.lld:pubmed
pubmed-article:8889583pubmed:languageenglld:pubmed
pubmed-article:8889583pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889583pubmed:citationSubsetIMlld:pubmed
pubmed-article:8889583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889583pubmed:statusMEDLINElld:pubmed
pubmed-article:8889583pubmed:issn1059-7794lld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:FlatmarkTTlld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:ApoldJJlld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:MartínezAAlld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:EikenH GHGlld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:KnappskogP...lld:pubmed
pubmed-article:8889583pubmed:authorpubmed-author:BrulandOOlld:pubmed
pubmed-article:8889583pubmed:issnTypePrintlld:pubmed
pubmed-article:8889583pubmed:volume8lld:pubmed
pubmed-article:8889583pubmed:ownerNLMlld:pubmed
pubmed-article:8889583pubmed:authorsCompleteYlld:pubmed
pubmed-article:8889583pubmed:pagination236-46lld:pubmed
pubmed-article:8889583pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:meshHeadingpubmed-meshheading:8889583-...lld:pubmed
pubmed-article:8889583pubmed:year1996lld:pubmed
pubmed-article:8889583pubmed:articleTitlePKU mutation (D143G) associated with an apparent high residual enzyme activity: expression of a kinetic variant form of phenylalanine hydroxylase in three different systems.lld:pubmed
pubmed-article:8889583pubmed:affiliationDepartment of Medical Genetics, Haukeland Hospital, University of Bergen, Norway.lld:pubmed
pubmed-article:8889583pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8889583pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8889583pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5053entrezgene:pubmedpubmed-article:8889583lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8889583lld:pubmed